The Hippo pathway controls organ size and tissue homeostasis, with deregulation leading to cancer. The core Hippo components in mammals are composed of the upstream serine/threonine kinases Mst1/2, MAPK4Ks and Lats1/2. Inactivation of these upstream kinases leads to dephosphorylation, stabilization, nuclear translocation and thus activation of the major functional transducers of the Hippo pathway, YAP and its paralogue TAZ 1, 2 . YAP/TAZ are transcription co-activators that regulate gene expression primarily through interaction with the TEA domain DNA-binding family of transcription factors (TEAD) 3 . The current paradigm for regulation of this pathway centres on phosphorylation-dependent nucleocytoplasmic shuttling of YAP/TAZ through a complex network of upstream components 2 . However, unlike other transcription factors, such as SMAD, NF-κB, NFAT and STAT, the regulation of TEAD nucleocytoplasmic shuttling has been largely overlooked. In the present study, we show that environmental stress promotes TEAD cytoplasmic translocation via p38 MAPK in a Hippo-independent manner. Importantly, stress-induced TEAD inhibition predominates YAP-activating signals and selectively suppresses YAP-driven cancer cell growth. Our data reveal a mechanism governing TEAD nucleocytoplasmic shuttling and show that TEAD localization is a critical determinant of Hippo signalling output.
The Hippo pathway controls organ size and tissue homeostasis, with deregulation leading to cancer. The core Hippo components in mammals are composed of the upstream serine/threonine kinases Mst1/2, MAPK4Ks and Lats1/2. Inactivation of these upstream kinases leads to dephosphorylation, stabilization, nuclear translocation and thus activation of the major functional transducers of the Hippo pathway, YAP and its paralogue TAZ 1, 2 . YAP/TAZ are transcription co-activators that regulate gene expression primarily through interaction with the TEA domain DNA-binding family of transcription factors (TEAD) 3 . The current paradigm for regulation of this pathway centres on phosphorylation-dependent nucleocytoplasmic shuttling of YAP/TAZ through a complex network of upstream components 2 . However, unlike other transcription factors, such as SMAD, NF-κB, NFAT and STAT, the regulation of TEAD nucleocytoplasmic shuttling has been largely overlooked. In the present study, we show that environmental stress promotes TEAD cytoplasmic translocation via p38 MAPK in a Hippo-independent manner. Importantly, stress-induced TEAD inhibition predominates YAP-activating signals and selectively suppresses YAP-driven cancer cell growth. Our data reveal a mechanism governing TEAD nucleocytoplasmic shuttling and show that TEAD localization is a critical determinant of Hippo signalling output.
We set out to identify signals that may regulate TEAD subcellular localization by focusing on conditions known to inhibit YAP/TAZ such as serum starvation 4 , energy stress by glucose starvation 5, 6 , PKA activation by forskolin 4 , disruption of the actin cytoskeleton by latrunculin B 7, 8 , Src inhibition by dasatinib 9 and inhibition of mevalonate synthesis by cerivastatin 10 . These well-known YAP/TAZ inhibitory stimuli indeed induced YAP/TAZ cytoplasmic localization, but failed to alter TEAD subcellular localization (Fig. 1a) . In contrast, environmental stresses such as osmotic stress, high cell density and cell detachment induced cytoplasmic translocation of TEAD and YAP/TAZ ( Fig. 1b and Supplementary Fig. 1a,b) , demonstrating that only a subset of signals that induce YAP/TAZ cytoplasmic localization are capable of driving TEAD cytoplasmic localization.
The p38 MAP kinase is activated by stress, including hyperosmotic conditions; therefore, we examined whether p38 plays a role in regulation of TEAD during stress. Treatment with p38 inhibitors (SB203580 or PH797840) blocked osmotic-stress-induced, but not high-density-induced, TEAD cytoplasmic localization, indicating that p38 is specifically involved in TEAD cytoplasmic translocation following osmotic stress ( Fig. 1c and Supplementary Fig. 1c ). Activation of p38 by ectopic expression of p38 and its upstream kinase MKK3 also induced cytoplasmic translocation of TEAD and this effect was blocked by p38 inhibitor treatment ( Fig. 1d and Supplementary Fig. 1d ). We predicted that all four isoforms of p38 may play compensatory roles as ablating TEAD translocation required concentrations of p38 inhibitor that were sufficient for inhibiting all p38 isoforms ( Supplementary Fig. 1e ). Deletion of p38α/β (p38 2KO) resulted in p38γ/δ upregulation and did not impede TEAD cytoplasmic translocation ( Supplementary Fig. 1f,g ), further supporting the pharmacological evidence that all four isoforms of p38 play a role in TEAD regulation. When all four p38 genes were deleted in the p38α/β/γ/δ knockout (KO) (p38 4KO) cells, TEAD localization was insensitive to osmotic stress and largely retained in the nucleus (Fig. 1e,f and Supplementary Fig. 1f,h ). Under basal conditions, deletion of p38 had no effect on TEAD localization and marginally increased YAP-TEAD activity, indicating that p38 plays a role in regulation of TEAD mainly under conditions of cellular stress ( Supplementary Fig. 1i,j) . The specific role of p38 in osmotic stress is further supported by the result that p38 inhibition or knockout had no effect on density-induced TEAD cytoplasmic localization ( Supplementary Fig. 1c) . Collectively, the above observations demonstrate a critical role of p38 in stress-induced TEAD nucleocytoplasmic translocation. Consequently, TEAD cytoplasmic translocation by osmotic stress suppressed YAP/TAZ target gene expression induced by YAP-activating signals, such as lysophosphatidic acid (LPA) and serum 4 , which was rescued by p38 inhibition (Fig. 1g,h ). The NaCl-induced cytoplasmic localization of TEAD was slower than p38 phosphorylation and activation (Fig. 1i,j ) but occurred concurrently with p38 dephosphorylation and cytoplasmic translocation (Fig. 1k) . It is well established that post osmotic stress, p38 undergoes dephosphorylation and cytoplasmic translocation, indicating that TEAD cytoplasmic translocation occurs during the adaptation phase of stress response 11 . To further gain mechanistic insight into TEAD regulation by p38, we investigated the role of p38 protein-protein interaction and kinase activity, both of which are critically involved in p38 signal transduction 12 . We sought to determine whether p38 directly interacts with TEAD to promote cytoplasmic translocation. Interestingly, osmotic stress induced endogenous TEAD-p38 interaction, whereas serum-induced TEAD-YAP interaction was abolished by osmotic stress (Fig. 2a-c) . In addition, exogenous p38 and MKK3 both showed interaction with TEAD (Fig. 2d) . Using bacterially purified proteins in an in vitro binding assay, we show that TEAD can interact directly with p38 without scaffold proteins (Fig. 2e) . Furthermore, p38 does not bind to YAP and thus regulates TEAD independently of YAP (Fig. 2f) . The D domain, found in p38 binding partners, serves as a docking site for p38 protein-protein interactions 12 . We identified a putative D domain that is highly conserved within the TEAD family (Fig. 2g) . Deletion of the D domain in TEAD abolished TEAD-p38 interaction (Fig. 2h) . Consistently, p38 CD/ED, a p38 mutant that has lost its ability to interact with D-domain-containing substrates 13, 14 , significantly dampened TEAD-p38 interaction and was unable to induce TEAD cytoplasmic translocation (Fig. 2i-l) . Ectopic expression of a kinase-deficient mutant, p38 KM, was also insufficient in binding to TEAD and driving cytoplasmic translocation (Fig. 2m,n) . To determine whether TEAD cytoplasmic translocation is due to p38-mediated phosphorylation, we constructed TEAD4-4SP, in which the four putative p38 phosphorylation sites were mutated to alanine ( Supplementary Fig. 2a ). Using an in vitro kinase assay, we found TEAD4 to be a poor substrate for p38 phosphorylation with complete ablation of phosphorylation in the TEAD4-4SP mutant, indicating the absence of alternative phosphorylation sites ( Supplementary  Fig. 2b-d) . Additionally, TEAD4-4SP displayed normal cytoplasmic translocation following osmotic stress ( Supplementary Fig. 2e ), suggesting that p38 kinase activity is required for TEAD interaction but does not directly phosphorylate TEAD to regulate its subcellular localization. Disruption of a putative TEAD nuclear export signal, as well as inhibition of chromosomal maintenance 1 (CRM1), a member of the importin family, using leptomycin B, largely ablated TEAD translocation, indicating that TEAD cytoplasmic translocation is an active, CRM1-mediated process ( Supplementary Fig. 2f-h ). In contrast to TEAD cytoplasmic localization, osmotic stress stimulates nuclear translocation of the transcription factor nuclear factor of activated T-cells 5 (NFAT5) 15 ; thus, TEAD cytoplasmic translocation is a specific cellular response following osmotic stress ( Supplementary Fig. 2i ).
Next, we tested the effect of stress-induced TEAD cytoplasmic sequestration on YAP activation. Under osmotic stress, YAP-activating signals, such as serum and LPA, failed to induce YAP dephosphorylation and nuclear accumulation (Fig. 3a,b) . ERK phosphorylation, however, was not affected, suggesting specificity of osmotic stress on YAP inhibition. Unexpectedly, stress evoked TEAD and YAP/TAZ cytoplasmic translocation in MAP4K 4/6/7, Mst1/2 and Lats1/2 KO cells, despite constitutively dephosphorylated YAP (Fig. 3c,d and Supplementary Fig. 3a-g ). These results indicate that stress-induced TEAD and YAP/TAZ cytoplasmic retention is a Hippo-independent process and uncouples YAP dephosphorylation from its nuclear localization. Consistently, p38 inhibition restored TEAD in the nucleus in Lats1/2 KO cells (Fig. 3d) . Compared with WT cells, p38 inhibition enhanced YAP/TAZ nuclear accumulation and target gene expression in the absence of Lats (Fig. 3d,e and Supplementary Fig. 3g ). To test whether nuclear TEAD is required for YAP nuclear translocation following activating signals, we generated TEAD1/2/4 KO cells. YAP-activating signals promoted normal YAP dephosphorylation in the TEAD KO cells, but failed to elicit nuclear YAP/TAZ accumulation (Fig. 3f,g ), suggesting that nuclear localization of TEAD is a prerequisite for proper YAP nuclear localization. No interaction was detected between YAP and p38, indicating that YAP cytoplasmic translocation is a consequence of TEAD regulation by p38 (Fig. 2f) . Our data suggest that YAP nuclear localization is contingent on two conditions, dephosphorylation and nuclear localization of TEAD.
YAP is highly active in many cancers, particularly in uveal melanoma (UM) and mesothelioma, due to mutations in upstream components of the Hippo pathway [16] [17] [18] . YAP was constitutively hypophosphorylated and nuclear in the mesothelioma cells MSTO-211H (Lats2 mutation) and H2373 (NF2 mutation), even under YAP-inhibitory conditions (Fig. 4a,b and Supplementary  Fig. 4a,b) . However, osmotic stress promoted cytoplasmic translocation of both TEAD and YAP/TAZ, and consequently suppressed anchorage-independent growth (Fig. 4a-c and Supplementary  Fig. 4a,b) . Importantly, ectopic expression of a fusion of the TEAD DNA-binding domain to the VP16 transactivation domain, which is constitutively active and p38 binding deficient, restored colonyforming ability of mesothelioma cells (Fig. 4c-e and Supplementary  Fig. 4c ), suggesting that osmotic-stress-induced growth arrest is due to TEAD inhibition. To further examine whether stress-induced TEAD inhibition selectively suppresses YAP-driven cancer cell growth, we compared a series of UM cell lines with mutations in either GNAQ or BRAF. The GNAQ-mutant UM cells are YAP-dependent, while the BRAF-mutant UM cells are YAP-independent ( Fig. 4f and Supplementary Fig. 4d ,e) 17 . We observed that osmotic stress evoked p38-dependent cytoplasmic translocation of TEAD and YAP/TAZ in both 92.1 (GNAQ Q209L ) and OCM1 (BRAF V600E ) cells ( Fig. 4g and Supplementary Fig. 4d-g ). However, TEAD inhibition by osmotic stress or stable expression of p38 preferentially suppressed anchorage-independent growth of GNAQ-mutant UM cell lines, 92.1, OMM2.2, OMM2.3, Mel202, Mel270, but not BRAF-mutant UM 
GST-TEAD4 cell lines, OCM1 and OCM8 ( Fig. 4h and Supplementary Fig. 4h ). Consistently, TEAD translocation induced apoptosis specifically in the YAP-driven 92.1 cells but not the YAP-independent OCM1 cells (Fig. 4i) . Furthermore, promotion of anchorage-independent growth by YAP-5SA transformation of MCF10A cells was also stunted by TEAD inhibition (Supplementary Fig. 4i ). These results indicate that YAP-driven cancer cells are highly susceptible to stress-induced TEAD inhibition. To further elucidate the role of TEAD inhibition on YAP-driven cancers, MSTO-211H cells were used as an isogenic model. Growth inhibitory effects resulting from stable expression of p38 were rescued by expression of constitutively active TEAD in vitro and in vivo (Fig. 4j-m and Supplementary Fig. 4j ). Under physiological osmotic stress, TEAD was cytoplasmic in tubule cells of normal kidney tissue, but was nuclear in malignant renal clear cell carcinoma as well as other normal tissues not exposed to osmotic stress ( Supplementary Fig. 4k-m) . Taken together, our results suggest that regulation of TEAD is important for modulating cancer growth and indicate TEAD as a potential therapeutic target. NaCl:
NaCl NaCl Data are presented as mean ± s.e.m. * P < 0.05; * * P < 0.01; P values were determined using one-way ANOVA followed by Tukey's multiple comparison test. (l) TEAD1/4-VP16 rescues p38-induced inhibition of MSTO-211H in vivo tumour xenograft growth. Nude mice were injected with control, p38− or p38+TEAD1/4-VP16-expressing MSTO-211H cells and tumour growth was measured at the indicated times. Data are presented as mean ± s.e.m. n = 4 mice per group. * * P < 0.01; * * * P < 0.001; P values were determined using two-way ANOVA. (m) Nude mice were injected with control, p38− or p38+ TEAD1/4-VP16-expressing MSTO-211H cells and tumours were harvested after 4 weeks. Only three tumours developed, out of eight injections, in the p38 group. Scale bar, 10 mm. Unprocessed original scans of blots are shown in Supplementary Fig. 5 .
In the present study, we report that the Hippo pathway transcription factor TEAD is regulated through nucleocytoplasmic shuttling. TEAD is regulated by different upstream signals with distinct mechanisms as compared with YAP/TAZ. Many signals, such as serum and energy status, which modulate the localization of YAP, have no effect on TEAD localization. We identified certain environmental stresses that can induce cytoplasmic TEAD translocation. In the case of osmotic stress, TEAD cytoplasmic translocation is mediated by p38 MAPK and independent of the Hippo core kinases. It should be noted that osmotic stress initially induces acute nuclear accumulation of YAP 19, 20 , then at later stages, induces cytoplasmic translocation of TEAD, and consequently YAP, as an adaptive response to stress. Mechanistically, osmoticstress-induced cytoplasmic TEAD translocation occurs via direct protein-protein interaction with p38, independent of Hippo. Disruption of TEAD-p38 interaction abolishes TEAD cytoplasmic translocation, resulting in nuclear retention of transcriptionally active TEAD. Cytoplasmic localization of TEAD is also observed in different cellular contexts, such as cell density that is p38-independent, as well as developmental contexts 21, 22 . Importantly, stress-induced TEAD inhibition predominates YAP-activating signals by preventing YAP nuclear accumulation, regardless of the phosphorylation status of YAP. Thus, inhibition of TEAD presents a Hippo-pathway-independent avenue of regulating YAP activity, thereby providing a mechanism of controlling its functional output without targeting the Hippo core components Mst and Lats. Moreover, stress-induced TEAD nucleocytoplasmic shuttling is intact in cancer cells that harbour mutations in Hippo pathway upstream components and renders YAP-driven cancer cells highly susceptible to stress-induced growth inhibition. Therefore, pharmacological agents that promote TEAD cytoplasmic localization may be a viable therapeutic strategy for treatment of cancers, especially those with high YAP activity.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper
Cell culture. All cell lines were maintained at 37 • C with 5% CO 2 . HEK293A cells were cultured in DMEM (Invitrogen, 11965118) and uveal melanoma and mesothelioma cell lines were cultured in RPMI (Invitrogen, 11875119) containing 10% FBS (Gibco, 10437028) and 50 µg ml −1 penicillin/streptomycin (Invitrogen, 15140122). MCF10A cells were cultured in DMEM-F12 supplemented with 5% horse serum (Invitrogen, 26050088), 20 ng ml −1 EGF (Peprotech, AF-100-15), 0.5 µg ml −1 hydrocortisone (Sigma, H4001-25G), 100 ng ml −1 cholera toxin (Sigma, C8052-2MG) and 10 µg ml −1 insulin (Sigma, I1882-100MG). YAP-inhibitory signals and environmental stresses included the following: serum starvation (16 h), glucose starvation (2-DG, 25 mM, 2 h), PKA activation (forskolin, 10 µM, 1 h), disruption of F-actin (latrunculin B, 0.1 µg ml −1 , 1 h), Src inhibition (dasatinib, 5 µM, 6 h), inhibition of the mevalonate synthesis (cerivastatin, 2 µM, 6 h), NaCl (200 mM, 6 h), sorbitol (0.5 M, 6 h), high cell density (2 day post-confluent) and cell detachment (1 h). No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not authenticated. Cells lines were tested and confirmed to be free of mycoplasma.
Induction of osmotic stress and p38 inhibitor treatment. Cells were treated with either 200 mM NaCl or 0.5 M sorbitol for 6 h. The p38 inhibitors SB203580 (S1076) (40 µM) and PH797840 (S2726) (30 µM) were purchased from Selleckchem and cells were treated 2 h prior to osmotic stress exposure.
Transfection and viral infection. Cells were transfected with plasmid DNA using PolyJet Reagent (Signagen Laboratories) according to the manufacturer's protocol. Cells were transfected with (pCDNA3) Flag-p38 or (pCDNA3) HA-p38, (pCDNA3) Flag-MKK3 and (pRK5) Myc-TEAD4.
92.1, OCM1 and MSTO-211H cells stably expressing empty vector; p38 and MKK3; and p38, MKK3 and TEAD1/4-VP16 were generated by retroviral and lentiviral infection. HEK293T packaging cells were transfected with empty vector, (pHIV puro) p38, (pQCXIH) MKK3 and (pHIV GFP) TEAD1/4-VP16 constructs. At 48 h after transfection, retroviral and lentiviral supernatant was filtered through a 0.45 µm filter, supplemented with 8 µg ml −1 Polybrene, and used for infection. At 48 h after infection, cells were selected with puromycin (1 µg ml −1 ) and hygromycin (200 µg ml −1 ) and FACS sorted for GFP expression. Antibodies. The following antibodies were purchased from Cell Signaling and used at the indicated dilution for western blot analysis, immunohistochemistry and immunofluorescence: pan-TEAD (13295, 1:1,000), p38 MAPK (8690, 1:1,000), phospho-p38 MAPK (4511, 1:1,000), YAP (14074, 1:1,000), TAZ (4883, 1:1,000), Lats1 (3477, 1:1,000), p-MK2 (3007, 1:1,000), p-ERK (4370, 1:1,000), DYKDDDDK tag (2368, 1:1,000), Myc tag (2276, 1:1,000), p38α (2371, 1:1,000), p38β (2339, 1:1,000), p38γ (2307, 1:1,000) and p38δ (2308, 1:1,000). The following antibodies were purchased from Santa Cruz Biotechnology and used at the indicated dilution for western blot analysis and immunofluorescence: YAP (sc-101199, 1:1,000), HA (sc-7392, 1:5,000), Myc (sc-40, 1:5,000), GAPDH (sc-25778, 1:1,000). TEAD4 (ab58310, 1:1,000) was purchased from Abcam, Flag (A8592, 1:10,000) and vinculin (V9131, 1:5,000) were purchased from Sigma, TEAD1 (610923, 1:1,000) was purchased from BD Biosciences, Lats2 (A300-479A, 1:1,000) was purchased from Bethyl Laboratories, and NFAT5 (bs-9473R OWL 1:1,000) was purchased from One World Lab.
Generation of knockout cells and mutagenesis. pSpCas9(BB)-2A-Puro (PX459) was a gift from F. Zhang (Broad Institute of MIT and Harvard, USA) (Addgene plasmid no. 48139; ref. 23). The nucleotide guide sequences were designed using the CRISPR design tool at http://crispr.mit.edu. Single-guide RNAs (sgRNAs) were cloned into the PX459 expression vector. HEK293A cells were transfected using PolyJet DNA in vitro Transfection Reagent according to the manufacturer's instructions. At 24 h post transfection, cells were selected with puromycin for 2-3 days. Following removal of puromycin, cells were allowed to recover in regular growth media for 24 h before being single-cell-sorted by FACs (UCSD; Human Embryonic Stem Cell Core, BDInflux) into a 96-well-plate format. Single clones were expanded and screened by protein immunoblotting, genomic sequencing and functional assays. Lats KO, Mst KO and MAP4K KO cells were generated as previously described 24, 25 . Guide sequences: p38α: 5 -3 AGCTCCTGCCGGTAGAACGT; p38β: 5 -3 CCA CGCGCGCAGAACGTACC; p38γ: 5 -3 GGACGGCCGCACCGGCGCTA; p38δ: 5 -3 TCCCCGACGCACGTCGGCAG; TEAD1: 5 -3 TGGCAGTGGCCGAGACG ATC; TEAD2: 5 -3 AGATAGGTGGGACGCCGGCG; TEAD4: 5 -3 CTCAAGGA TCTCTTCGAACG.
p38 and TEAD site-directed mutagenesis was carried out using Q5 Hot Start High Fidelity DNA Polymerase from New England Biolabs (M0494) per the manufacturer's protocol.
RNA extraction, cDNA synthesis and quantitative real-time PCR analysis. Cells were harvested for RNA extraction using the RNeasy Plus mini kit (QIAGEN, 74136). RNA samples were reverse-transcribed to complementary DNA (cDNA) using iScript reverse transcriptase (Bio-Rad, 1708891). qRT-PCR was performed using the KAPA SYBR FAST qPCR kit (Kapa Biosystems, KK4605) and the 7300 real-time PCR system (Applied Biosystems).
Primer sequences used were as previously described 4, 24 .
Immunofluorescent microscopy. Cells were seeded in 12-well plates on coverslips 2 days prior to experimentation. Coverslips were pretreated with poly-L-ornithine solution (Sigma, P4957) diluted 1:20 at 37 • C for 15 min with a quick phosphatebuffered saline (PBS) wash prior to cell seeding. Cells were fixed in 4% paraformaldehyde (Electron Microscopy Sciences, 2280) for 15 min followed by permeabilization with 0.1% Triton-X for 5 min. Cells were blocked in 3% BSA for 1 h and incubated overnight at 4 • C in primary antibodies diluted in 3% BSA. Secondary antibodies were diluted in 3% BSA and incubated for 1 h. Slides were mounted with Prolong gold antifade reagent with DAPI (Invitrogen, P36931). Each image is a single Z section at the same cellular level. Images were captured with a Nikon Eclipse Ti confocal microscope. Images depicted in figures were exported from NIS elements imaging software.
Immunohistochemistry. Kidney tissue arrays were purchased from US Biomax. Tissues were subject to heat-induced antigen retrieval using 10 mM sodium citrate buffer followed by 3% H 2 O 2 for 30 min to quench endogenous peroxidase activity. Sections were incubated overnight at 4 • C with pan-TEAD antibody and detected using Vectastain elite ABC kit and DAB Peroxidase Substrate kit (Vector Laboratories) as per the manufacturer's protocol.
Western blot and immunoprecipitation. Immunoblotting was performed using a standard protocol. Phos-tag reagents were purchased from Wako Chemicals, and gels containing phos-tag were prepared according to the manufacturer's instructions. For immunoprecipitations, cells were rinsed twice with ice-cold PBS and lysed in ice-cold lysis buffer (0.15 M NaCl, 0.05 M Tris-HCl, 0.5% Triton X-100, and one tablet each of EDTA-free protease inhibitors (Roche, 11873580001) and phosphatase inhibitor (Thermo Fisher, 88667) per 50 ml). For immunoprecipitations, primary antibodies were added to the lysates and incubated with rotation overnight at 4 • C. Ten microlitres of magnetic protein A/G beads (Thermo Fisher, 88802) were added and incubated for an additional 2 h. Immunoprecipitates were washed three times with lysis buffer. Immunoprecipitated proteins were denatured by the addition of sample buffer and boiling for 5 min, resolved by 9% SDS-PAGE, and analysed via western blot analysis.
In vitro kinase assay. To analyse p38 kinase activity, HEK293A cells were transfected with WT or kinase mutant p38α. p38γ and p38δ were purchased from SignalChem. Cells were collected and p38 was immunoprecipitated as described above. Immunoprecipitates were washed with kinase assay buffer (25 mM HEPES pH 7.4, 25 mM MgCl 2 and 2 mM dithiothreitol) and subjected to a kinase assay in kinase assay buffer along with 500 µM AT-γ-S. GST-ATF2, GST-TEAD4 or GST-TEAD4-4SP fusion proteins were used as substrates. Reactions were incubated for 30 min at 30 • C. p-Nitrobenzyl mesylate (Sigma, A1388) was added to the kinase reactions and incubated for 1 h to alkylate the thiophosphorylation sites on the substrates. Reactions were terminated with sample buffer and resolved on 9% SDS-PAGE. A thiophosphate ester antibody (Abcam, ab92570) was used to detect substrate phosphorylation.
Soft agar colony growth. Each 6-well plate was coated with 1.5 ml of bottom agar (DMEM containing 10% FBS and 0.5% Difco agar noble). Various cells (5 × 10 3 ) were suspended in 1.5 ml of top agar (DMEM containing 10% FBS and 0.35% Difco agar noble) into each well. Cells were incubated for approximately three weeks and DOI: 10.1038/ncb3581 replaced with fresh medium containing 50 mM NaCl every three days. Colonies were stained using 0.005% crystal violet. Figure S1
Statistics
Supplementary Figure 1 Osmotic stress induces TEAD cytoplasmic translocation. a, Time course of osmotic stress-induced TEAD cytoplasmic translocation. HEK293A cells were treated with NaCl for 0, 1, 3, or 6 hours and stained for immunofluorescence. b, Dose response for NaCl-induced TEAD cytoplasmic translocation. HEK293A cells were stimulated with different concentrations of NaCl for 6 hr and stained for immunofluorescence. TEAD cytoplasmic translocation occurs from100mM NaCl. c, High cell density-induced TEAD cytoplasmic localization is p38 independent. Immunofluorescence shows inhibition or KO of p38 upon high cell density has no effect on TEAD cytoplasmic translocation. d, Cells ectopically expressing MKK3/p38 were stained for immunofluorescence. MKK3/p38 promotes TEAD4 cytoplasmic translocation. e, Dose response for p38 inhibitor treatment. HEK293A cells were pre-treated with different doses of p38 inhibitors as indicated, followed by NaCl stimulation and stained for immunofluorescence. f, Western blot of p38α/β knockout cells show upregulation of p38δ/γ isoforms. g, p38 2KO cells were stained for immunofluorescence. Deletion of p38α/β isoforms is not sufficient to inhibit TEAD cytoplasmic translocation. h, Immunoblotting for p-p38 in p38 4KO cells shows impaired p38 activity under various p38 activating stimuli (200 mM NaCl, 500 µM sorbitol, 500 µM arsenite). i,j p38 4KO shows no effect on TEAD localization No phosphorylation or weak phosphorylation was detected in TEAD4 WT, which was further ablated in TEAD4-4SP, whereas ATF2 was effectively phosphorylated by p38. e, Detection of TEAD4-4SP cytoplasmic translocation by p38 using immunofluorescence. f, Sequence of putative TEAD nuclear export signal. g, TEAD cytoplasmic translocation requires a nuclear export sign al. Immunofluorescence shows truncation of TEAD disrupting a putative nuclear export signal in TEAD (1-382) mutant inhibits CRM1-dependent TEAD nuclear export compared to full length TEAD. h, TEAD cytoplasmic translocation is a CRM1-dependent process. HEK293A cells were pretreated with LMB for the indicated times followed by NaCl stimulation and staining for immunofluorescence. Pretreatment with LMB inhibits TEAD cytoplasmic translocation. 
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Replication
Describe whether the experimental findings were reliably reproduced. All replication attempts were successful
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
8-12 week female nude mice were chosen as xenograft hosts. As the mice age they lose immune deficiency, thus 8-12 week mice are ideal. Female mice were chosen as aggressive behavior among male mice may affect measurements of tumor growth. Mice were randomly allocated into experimental groups.
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No blinding was carried out.
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Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
The following antibodies were purchased from Cell Signaling and used at the indicated dilution for western blot analysis, immunohistochemistry, and immunofluorescence: pan-TEAD (D3F7L) (13295, 1:1000), p38 MAPK (D13E1) (8690, 1:1000), phospho-p38 MAPK (D3F9) (4511, 1:1000), YAP (D8H1X) (14074, 1:1000), TAZ (4883, 1:1000), Lats1 (C66B5) (3477, 1:1000), p-MK2 (27B7) (3007, 1:1000), p-ERK (D13.14.4E) (4370, 1:1000), DYKDDDDK tag (2368, 1:1000), Myc tag (9B11) (2276, 1:1000), p38a (7D6) (2371, 1:1000), p38b (C28C2) (2339, 1:1000), p38g (2307, 1:1000), and p38d (10A8) (2308, 1:1000). The following antibodies were purchased from Santa Cruz Biotechnology and used at the indicated dilution for western blot analysis and immunofluorescence: YAP (63.7) (sc-101199, 1:1000), HA (F-7) (sc-7392, 1:5000), Myc (9E10) (sc-40, 1:5000), GAPDH (sc-25778, 1:1000). TEAD4 (ab58310, 1:1000) was purchased from Abcam, Flag (M2) (A8592, 1:10,000) and vinculin (hVIN-1) (V9131, 1:5000) was purchased from Sigma, TEAD1 (31) (610923, 1:1000) was purchased from BD Biosciences, Lats2 (A300-479A, 1:1000) was purchased from Bethyl Laboratories, and NFAT5 (bs-9473R OWL 1:1000) was purchased from One World Lab. No cells lines listed in the paper are in the database of commonly misidentified cell lines.
